3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing for Drain Site Complication

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
NYU Langone Health, New York, NYDrain Site Complication3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test if using chlorhexidine gluconate on surgical drains can help prevent infection better than using dry gauze.

Eligible Conditions
  • Drain Site Complication

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Phasix™ Mesh
1
Dermabond Prineo Skin Closure System
3
Antiseptic Cleanser

Study Objectives

6 Primary · 4 Secondary · Reporting Duration: up to Month 6

Month 6
Change in Erythema Measurement
Change in distance between skin changes and normal looking skin
Number of participants in each category of quality of drainage (serous, sanguineous, or purulent)
Up to Month 6
Number of participants who experience pain post-op
Total amount of drainage from drain site
up to Month 6
Antibiotic prescription rate
Number of participants displaying presence of hematoma
Number of participants displaying signs of wound infection
Number of participants displaying sterility of seroma
Number of participants in each category of skin induration (flat, soft, or firm)

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Phasix™ Mesh
1
Dermabond Prineo Skin Closure System
3
Antiseptic Cleanser

Trial Design

2 Treatment Groups

Standard of Care
1 of 2
Chlorhexidine Gluconate Gel Dressing
1 of 2

Active Control

Experimental Treatment

300 Total Participants · 2 Treatment Groups

Primary Treatment: 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing · No Placebo Group · N/A

Chlorhexidine Gluconate Gel Dressing
Device
Experimental Group · 1 Intervention: 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing · Intervention Types: Device
Standard of CareNoIntervention Group · 1 Intervention: Standard of Care · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to month 6

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,279 Previous Clinical Trials
755,991 Total Patients Enrolled
David Chiu, MDPrincipal InvestigatorNYU Langone Health
2 Previous Clinical Trials
78 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

Are recruits still being taken on for this clinical trial?

"Affirmative. Evidently, the clinical trial is seeking more participants as it was last updated on August 24th 2022 and is looking to enrol 300 patients from a single medical centre." - Anonymous Online Contributor

Unverified Answer

How many people have been recruited to participate in this experiment?

"Affirmative. Clinicaltrials.gov hosts the data which confirms that this research endeavor is presently open to applicants; it was initially advertised on 1/1/2021 and last updated on 8/24/2022. Three hundred volunteers are needed from a single site for participation purposes." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top